PFAS Food Packaging Agreement Reached Between FDA and Manufacturers

Aug 4, 2020 | Environmental, PFAS, Toxic Tort

In a press release published on July 31, 2020, the US Food and Drug Administration (FDA) announced that three manufacturers of products containing the specific per- and polyfluoroalkyl substance (PFAS) 6:2 fluorotelomer alcohol (6:2 FTOH) have agreed to voluntarily phase-out its use.  The three manufacturers that reached the agreement with the FDA were Archroma, AGC Chmicals, and Daikin America. The phase out will begin in 2021 and will be completed by 2023, under the agreement. However, the companies will be allowed to deplete their stocks of the PFAS-containing products for 18 months after 2023.

6:2 FTOH is used as a grease-proofing agent in food packaging, and recent rodent studies by the FDA raised questions about its bio persistence by “suggest[ing] the potential of 6:2 FTOH to also persist in humans from chronic dietary exposure”. However, the agency says that “further scientific studies are needed to better understand the potential human health risks.” Nevertheless, despite very little scientific studies on this issue, many companies that utilize PFAS in their products are changing course in light of the increasing pressure that PFAS has come under in the media.

CMBG3 Law is following judicial, legislative, administrative, and scientific developments relating to PFAS. More information about the services we can provide, including risk assessments, to ensure your business is ready for any intersection with these substances can be found on our PFAS Litigation page.

Our attorneys have been at the forefront of PFAS issues, including giving presentations as to the future waves of litigation stemming from PFAS issues. For more information, please contact any of our PFAS – Toxic Torts Team: Jessica Deyoe, Suzanne Englot, Alexandra Fraher,or John Gardella.

Written By:

John Gardella, Esq.


Submit a Comment

Your email address will not be published. Required fields are marked *



To be notified when a new article is available, please subscribe below.